Were thrilled to be at ESMO18 presenting abstracts spanning our marketed medicines and latestage portfolio Visit our press kit page to learn more about our dedication to developing advanced treatments for cancer patients httpson.pfizer.com2CUs0

We’re thrilled to be at #ESMO18 presenting abstracts spanning our marketed medicines and late-stage portfolio! Visit our press kit page to learn more about our dedication to developing advanced treatments for cancer patients https://on.pfizer.com/2CUs0

13:59 EDT 19 Oct 2018 | Pfizer

We’re thrilled to be at #ESMO18 presenting abstracts spanning our marketed medicines and late-stage portfolio! Visit our press kit page to learn more about our dedication to developing advanced treatments for cancer patients https://on.pfizer.com/2CUs0km  pic.twitter.com/Ox0DDm9B90

More From BioPortfolio on "We’re thrilled to be at #ESMO18 presenting abstracts spanning our marketed medicines and late-stage portfolio! Visit our press kit page to learn more about our dedication to developing advanced treatments for cancer patients https://on.pfizer.com/2CUs0"